J&J Can’t Get $70 Million Risperdal Award Tossed on Appeal

Bookmark
(Bloomberg) -- A Pennsylvania appeals court upheld a $70 million verdict against Johnson & Johnson in a lawsuit charging its Risperdal anti-psychotic drug caused a man to grow female breasts and al...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.